tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CMVLF Stock Latest News

Cellectis price target raised to $4 from $3 at Wells Fargo
The FlyCellectis price target raised to $4 from $3 at Wells Fargo
1d ago
CLLS
Cellectis price target raised to $8 from $4 at Barclays
PremiumThe Fly
Cellectis price target raised to $8 from $4 at Barclays
4d ago
CLLS
Cellectis SA’s Promising Study on UCART20x22 for B-Cell Non-Hodgkin Lymphoma
PremiumCompany Announcements
Cellectis SA’s Promising Study on UCART20x22 for B-Cell Non-Hodgkin Lymphoma
1M ago
CMVLF
Cellectis SA: Hold Rating Amid Upcoming Data Presentations and Financial Considerations
PremiumRatings
Cellectis SA: Hold Rating Amid Upcoming Data Presentations and Financial Considerations
2M ago
CLLS
Cellectis S.A. Advances UCART123 Clinical Study in AML Treatment
PremiumCompany Announcements
Cellectis S.A. Advances UCART123 Clinical Study in AML Treatment
2M ago
CLLS
Cellectis Reports Q2 2025 Results and Strategic Updates
PremiumCompany AnnouncementsCellectis Reports Q2 2025 Results and Strategic Updates
3M ago
CMVLF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CMVLF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Cellectis files $200M mixed securities shelf
Premium
The Fly
Cellectis files $200M mixed securities shelf
4M ago
CLLS
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
PremiumRatings
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
5M ago
CLLS
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
PremiumRatings
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
5M ago
CLLS
Cellectis price target lowered to $4 from $5 at Barclays
PremiumThe Fly
Cellectis price target lowered to $4 from $5 at Barclays
5M ago
CLLS
Cellectis SA Reports Q1 2025 Financial Results
PremiumCompany Announcements
Cellectis SA Reports Q1 2025 Financial Results
5M ago
Is CMVLF a Buy, Before Earnings?
PremiumPre-EarningsIs CMVLF a Buy, Before Earnings?
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
ALT
CLLS
Cellectis Reports 2024 Financial Results and Strategic Progress
Premium
Company Announcements
Cellectis Reports 2024 Financial Results and Strategic Progress
7M ago
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
PremiumRatings
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
7M ago
CLLS
Cellectis Reports 2024 Financial Results and Strategic Advances in CAR T-Cell Therapies
PremiumCompany Announcements
Cellectis Reports 2024 Financial Results and Strategic Advances in CAR T-Cell Therapies
7M ago
Cellectis Advances Clinical Programs and Strengthens AstraZeneca Partnership
PremiumCompany Announcements
Cellectis Advances Clinical Programs and Strengthens AstraZeneca Partnership
7M ago
Cellectis reports Q4 EPS (64c) vs (17c) last year
PremiumThe Fly
Cellectis reports Q4 EPS (64c) vs (17c) last year
7M ago
AZN
CLLS
Cellectis files to sell 44M ordinary shares for holders
PremiumThe FlyCellectis files to sell 44M ordinary shares for holders
9M ago
CLLS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
10M ago
BLRX
CLLS
Cellectis SA: Financial Growth Amidst Strategic Partnerships
Premium
Company Announcements
Cellectis SA: Financial Growth Amidst Strategic Partnerships
12M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >